Hp and pH: Implications for the Eradication of Helicobacter pylori

References

• Osier W. Diseases of the stomach. The principles and practice of medicine. 6th ed. Appleton, New York 1905; 456–7
   Google Scholar
• Hunt R H. Spontaneous hypochlorhydria. Campylobacter pylori and gastroduodenal disease. 2nd ed., B J Rathbone, R V Heatley. Blackwell Scientific, Oxford 1992; 176–83
   Google Scholar
• Morris A, Nicholson G. Campylobacterpyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–9
   PubMed Web of Science ®Google Scholar
• Defize J, Goldie J, Hunt R H. Effect of Campylobacter pylori on acid production by isolated guinea pig cells. Gut 1988; 29: A1435
   Web of Science ®Google Scholar
• Cave D R, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; 2: 187–9
   PubMed Web of Science ®Google Scholar
• Uehara A, Okumara T, Sekiya C, Okamura K, Takasugi Y, Namiki M. Interleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandins. Biochem Biophys Res Commun 1989; 162: 1578–84
   PubMed Web of Science ®Google Scholar
• Robert A, Olafsson A S, Lancaster C, Zhang W. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach and retards gastric emptying. Life Sci 1991; 48: 123–34
   PubMed Web of Science ®Google Scholar
• Rademaker J W, Hunt R H. H. pylori and gastric acid secretion: the ulcer link?. Scand J Gastroenterol 1992; 26(Suppl 187)71–7
   Google Scholar
• Mullin G E, Kalloo A N. Does Helicobacter pylori infection affect gastric acid secretion?. Gastroenterology 1990; 98: A92
   Google Scholar
• Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167–8
   PubMed Web of Science ®Google Scholar
• Wagner S, Gebel M, Bar W, Sculler A, Schmidt F W. The significance of Campylobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer disease. Gastroenterology 1990; 98: A145
   Google Scholar
• Walsh J H, Richardson C H, Fordtran J S. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462–8
   PubMed Web of Science ®Google Scholar
• Graham D Y, Opekim A, Lew G M. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990; 85: 394–8
   PubMed Web of Science ®Google Scholar
• Graham D Y, Opekum A, Lew G M. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea infusion. Gastroenterology 1991; 100: 1571–5
   PubMed Web of Science ®Google Scholar
• Karnes W E, Ohning G W, Sytnik B. Preservation of pH inhibition of gastrin release in subjects with Helicobacter pylori. Rev Infect Dis 1991; 13: S665–70
   Google Scholar
• McColl K E, Fullarton G M, Chittajalu R. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 226: 339–46
   Google Scholar
• Rangachari P K. Helicobacter pylori and hypergastrinaemia: the quisling option. Scand J Gastroenterol 1991; 26(Suppl 187)85–90
   Google Scholar
• Calam J, Levi S, Beardshall K. Helicobacter pylori and duodenal ulcer–the gastrin link. Helicobacter pylori, gastritis and peptic ulcer, P Malfertheiner, H Ditschu-Neit. Springer Verlag, Berlin 1990; 317–26
   Google Scholar
• Chittajallu R S, Neithercut W D, Ardill J ES, McColl K EL. Helicobacter pylori related hypergastrinaemia is not due to elevated antral surface pH. Scand J Gastroenterol 1992; 27: 218–22
   PubMed Web of Science ®Google Scholar
• Teichmann R K, Andress H J, Gycha S. Immunologic mediated gastrin release. Gastroenterology 1983; 84: 1333
   Web of Science ®Google Scholar
• Kramling H J, Enders G, Teichmann R K. Antigen induced gastrin release: an immunologic mechanism of gastric antral mucosa. Adv Exp Med Biol 1987; 216A: 427–9
   PubMedGoogle Scholar
• McColl K EL, Dorrian C, El-Nujumi A. Eradication of Helicobacter pylori reduces hypergastrinaemia due to proton pump inhibitor therapy. Gut 1991; 32: A564
   Google Scholar
• Calam J, Goodlad R A, Lee C Y. Achlorhydria-induced hypergastrinaemia: the role of bacteria. Clin Sci 1991; 80: 281–4
   Google Scholar
• Samloff I M, Liebman W M, Panitch N M. Serum group I pepsinogen by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 1975; 30: 912–6
   Google Scholar
• Samloff I M, Varis K, Ihamaki T, Siurala M, Rotter J I. Relationship among serum pepsinogen I and II, and gastric mucosal histology. Gastroenterology 1982; 83: 204–9
   PubMed Web of Science ®Google Scholar
• Unge P, Gad A, Gnarpe H. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis?. Scand J Gastroenterol 1989; 24(Suppl 167)49–54
   Web of Science ®Google Scholar
• Iwahi T, Satoh H, Nakao M. Lansoprazole, a novel benz-imidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490–6
   PubMed Web of Science ®Google Scholar
• Mainguet P, Delmee M, Debongnie J P. Omeprazole, Campylobacter pylori, and duodenal ulcer. Lancet 1989; 2: 389–90
   PubMed Web of Science ®Google Scholar
• Burget D W, Chiverton S C, Hunt R H. Is there an optimal degree of acid suppression for healing of duodenal ulcers?. Gastroenterology 1990; 99: 345–51
   PubMed Web of Science ®Google Scholar
• Rauws E AJ, Langenberg W, Houthoff H J, Zanen H C, Tytgat G NJ. Campylobacter pyloridis-associaled chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
   PubMedGoogle Scholar
• Bayerdörffer E, Ottenjann R. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol 1988; 23(Suppl 142)93–100
   Google Scholar
• Chiba N, Rao B V, Rademaker J W, Hunt R H. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716–27
   PubMed Web of Science ®Google Scholar
• Lamouliatte H, Vincon G, Quentin-Nourry C. Pharmacokinetics of oral and intravenous amoxycillin in human gastric mucosa. Gastroenterology 1992; 102: A107
   Google Scholar
• Van Zanten S JO, Goldie J, Hollingsworth J, Siletti C, Richardson H, Hunt R H. Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori. J Clin Pathol 1992; 45: 225–7
   PubMedGoogle Scholar
• Bell G D, Powell K, Weil J. Experience with omeprazole in combination with either amoxycillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3: 923–6
   Web of Science ®Google Scholar
• Unge P, Eriksson K, Bergman B. Omeprazole and amoxicillin in patients with duodenal ulcer: effect on Helicobacter pylori eradication and ulcer relapse during a 6-month follow-up. Gastroenterology 1992; 102: A183
   Google Scholar
• Chiverton S G, Howden C W, Burget D W, Hunt R H. Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration. Ailment Pharmacol Ther 1992; 6: 103–11
   PubMedGoogle Scholar
• Labenz J, Gyenes E, Riihl G H, Borsch G. Efficacy of omeprazole and amoxycillin to eradicate Helicobacter pylori. Am J Gastroenterol 1992; 87: 1271
   Google Scholar
• Bayerdorffer E, Mannes G A, Sommer A. High dose omeprazole treatment combined with amoxycillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697–702
   Web of Science ®Google Scholar
• Labenz J, Gyenes E, Riihl G H, Borsch G. Short term therapy with high dose omeprazole and amoxycillin for eradication of Helicobacter pylori. Ital J Gastroenterol 1991; 23(Suppl 2)109
   Google Scholar
• Logan R PH, Poison R J, Baron J H, Misiewicz J J. Follow-up after anti-Helicobacter pylori treatment. Lancet 1991; 337: 562–3
   PubMedGoogle Scholar
• Hosking S W, Ling T KW, Yung M Y. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992; 305: 502–4
   PubMed Web of Science ®Google Scholar